ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Ridaforolimus on the Pharmacokinetics of Midazolam (Study MK-8669-044)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01071304
Recruitment Status : Completed
First Posted : February 19, 2010
Last Update Posted : April 10, 2015
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.